Literature DB >> 15003905

Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.

Paolo De Fabritiis1, Teresa Dentamaro, Alessandra Picardi, Laura Cudillo, Mario Masi, Sergio Amadori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15003905

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  5 in total

Review 1.  Recombinant factor VIIa: a review on its clinical use.

Authors:  Massimo Franchini
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

Review 2.  The use of recombinant activated factor VII in platelet disorders: a critical review of the literature.

Authors:  Massimo Franchini
Journal:  Blood Transfus       Date:  2009-01       Impact factor: 3.443

3.  Recombinant activated factor VII as an additional agent in the management of bleeding in patients with chemotherapy-induced thrombocytopenia.

Authors:  Pavol Hollý; Lenka Lisá; Ivana Plameňová; Miroslava Dobrotová; Peter Kubisz
Journal:  Blood Transfus       Date:  2012-12-06       Impact factor: 3.443

4.  Use of recombinant factor VIIa in uncontrolled gastrointestinal bleeding after hematopoietic stem cell transplantation among patients with thrombocytopenia.

Authors:  Yaqiong Tang; Qian Wu; Xiaojin Wu; Huiying Qiu; Aining Sun; Changgeng Ruan; Depei Wu; Yue Han
Journal:  Pak J Med Sci       Date:  2015 Nov-Dec       Impact factor: 1.088

Review 5.  Clinical review: Traumatic brain injury in patients receiving antiplatelet medication.

Authors:  Christopher Beynon; Daniel N Hertle; Andreas W Unterberg; Oliver W Sakowitz
Journal:  Crit Care       Date:  2012-07-26       Impact factor: 9.097
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.